findmyKOL

Kathryn Bollin, MD

Basic profile

Scripps Clinic

ORCIDNPI
RegionSan Diego, CA · WestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Kathryn Bollin is an Oncology physician affiliated with Scripps Clinic. OpenAlex indexes 35 publications with 612 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
35publications

Distinct works indexed by OpenAlex, matched via ORCID.

612citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
42companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

501 Washington St Ste 508
San Diego, CA 921032238

Telephone

619-849-4469

Provider last certified this registry record 2 Jan 2020.

View the NPPES registry record

Industry payments

42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    87.1%
    PD-1 inhibitor87%
    Pembrolizumab56%Nivolumab44%
    Part B, office-administered20 patients
    Kinase inhibitor0.1%
    Mekinist54%Tafinlar46%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    11.5%
    Substance P/Neurokinin-1 Receptor Antagonist10.3%
    Aprepitant100%
    Part B, office-administered11 patients
    Serotonin-3 Receptor Antagonist1%
    Granisetron hydrochloride96%Ondansetron Hcl4%
    Part D + Part B16 patients

    + 3 more classes in this area

  • Sensory organs

    0.9%
    Corticosteroid0.9%
    Dexamethasone sodium phosphate96%Dexamethasone5%
    Part D + Part B14 patients
Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”